VENUSREM₹1,404.30-2.58%
76/100
0100 · strongest
strong
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %VENUSREM financial summary
For Mar 2026, Venus Remedies Ltd reported revenue of ₹765 crore, which grew 20.3% from the previous year. Net profit was ₹99 crore, which grew 86.8% year on year, on an operating margin of 19%. Earnings per share came in at ₹74.29. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹765 crore |
|---|---|
| Net profit | ₹99 crore |
| Operating margin | 19% |
| EPS | ₹74.29 |